Form 4: SpartanNash Director Julien Mininberg Awarded Restricted Stock Units

Director Julien Mininberg received 7,745 Restricted Stock Units (RSUs) under the SpartanNash Company 2020 Stock Incentive Plan, vesting on March 15, 2025.

Summary

• Julien Mininberg, a director of SpartanNash Co, was granted 7,745 Restricted Stock Units (RSUs) on March 5, 2024.
• The RSUs were awarded under the SpartanNash Company 2020 Stock Incentive Plan.
• These RSUs will vest on March 15, 2025, and each RSU represents the right to receive one share of SpartanNash common stock upon vesting.
• Prior to vesting, the RSUs are subject to restrictions according to the Plan's terms.
• A Power of Attorney is in place, authorizing Ileana McAlary, G. Charles Goode, Daniel C. Persinger, and Emily E. Cantor to act on behalf of Julien Mininberg for SEC filings related to SpartanNash securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of RSUs is a standard practice and indicates confidence in the company's future performance. It aligns the director's interests with those of shareholders.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing long-term value creation.

Future Outlook

The RSUs will vest on March 15, 2025, contingent on the terms of the SpartanNash Company 2020 Stock Incentive Plan.

Industry Context

Granting stock-based compensation to directors is a common practice in publicly traded companies to align their interests with those of shareholders and incentivize long-term growth.

Comparison to Industry Standards

• Stock grants to board members are a common practice among publicly traded companies, including competitors like Kroger, Albertsons, and Sysco.
• The size of the grant is likely determined by a number of factors including company performance, board member responsibilities, and industry benchmarks.

Stakeholder Impact

• The RSU grant aligns the director's interests with shareholders, potentially leading to decisions that benefit shareholder value.

Key Dates